direct organism identification from positive blood ... harris.pdf · proteus mirabilis 4 4/4 4/4...
TRANSCRIPT
Direct Organism Identification
From Positive Blood Cultures
using MALDI-TOF Biotyper
(Bruker Daltonics GmbH)
Rhian Harris
Contents
• What is MALDI-TOF and how does it work?
• Aims
• Introduction
• Methods
• Results
• Discussion and conclusions
• Future developments
What is MALDI-TOF and how does
it work?
• MALDI - TOF is an
abbreviation for Matrix assisted
laser desorption/ionisation -
time of flight
• The instrument consists of a
platform, a tube, a laser and a
detector.
What is MALDI-TOF and how does
it work?
• The organism which is being identified smeared onto the steel plate
• Fixed with matrix
• Cells are ionised using a laser which is fired at the plate
• Laser fires 240 times
What is MALDI-TOF and how does
it work?
• The ions present are then accelerated up the tube
• The greater the molecular weight of the ions the longer the time of flight
• The time it takes for the ions to reach the detector is measured and converted to Daltons(Da)/molecular weight.
• Each ion will represent a peak on the graph
What is MALDI-TOF and how does
it work?
• Collectively will form a unique fingerprint for each organism
• The spectra produced is compared to the Bruker database of approximately 4111 organisms with different spectra and scored
• An identification is given in approximately 30-60 seconds
Scoring system
Three Calculations
Unknowns in reference (6/10)
Reference peaks in unknown
(6/20)
Score of relative intensities of
matching peaks (out of 10)
6 x 3 x Intensity Score
Total score out of 1000
Log10 score out of 3
New Scoring system for Blood Cultures
Old Scoring New Scoring Meaning
>2.0 >1.8 Highly Probable Species
Identification
1.7-2.0 1.6-1.8 Probable Genus Identification
<1.7 <1.6 Non Reliable Genus
Identification
Aim
• The aim of this study was to determine if the Bruker
Sepsityper kit was able to successfully identify the micro-
organisms present in positive blood cultures by direct
extraction using Bruker Biotyper MALDI-TOF technology.
• The potential value of earlier species identification with
regard to clinical management and potential escalation
or de-escalation of antimicrobial treatment.
Introduction
• Blood cultures are an essential laboratory diagnosis tool to diagnose and determine treatment of a potential bacteraemia.
• The current method of detection of a positive blood culture involves the use of BioMerieux BacTalert system.
• Once removed a Gram film is carried out to determine the presence of any potential pathogens, and cultures performed to confirm the identification of the pathogen by BD Phoenix, a process which can take up to 48 hours.
• Early species identification may have clinical management implications and may also affect the antimicrobial therapy administered to the patient.
• MALDI-TOF mass spectrometry can revolutionise this process.
• MALDI-TOF-MS applied to positive blood cultures can yield a species identification result in <1 hour.
Introduction
• 78 Blood cultures
• 55 cultured organisms
• Processed using the Sepsityper kit
• Partly processed at RGH and Royal
Liverpool
• Processed every positive BC
Sepsityper BC method
• 1ml of Blood fluid
• 200µl of Lysis buffer
• Centrifuge for 1 min at 13,000 rpm
• Remove supernatant
• Re-suspend pellet with 1ml of washing buffer
• Centrifuge for 1 min at 13,000 rpm
• Remove supernatant
• 300µl deionised water and 900µl ethanol
• Samples were then frozen and taken to Liverpool for processing
Sepsityper BC method
• Centrifuge for 2 min at 13,000 rpm
• Remove supernatant
• Centrifuge for 2 min at 13,000 rpm
• Dry ethanol pellet
• Between 2 - 50µl formic acid added depending on size of pellet, and an equal volume of acetonitrile
• Centrifuge for 2 min at 13,000 rpm
• 1µl of the supernatant is spotted onto the target plate
• When dried the matrix was then added
ResultsOrganism No No ID by Maldi No ID by PHX Therapy Therapy Altered
E.coli 24 23/24 24/24 23/24 0/24
Staph.epidermidis 35 33/35 23/23 8/35 2/35
Candida albicans 2 1/2 0/2 0/2 0/2
Proteus mirabilis 4 4/4 4/4 4/4 0/4
Staph.pettenkeri 2 2/2 Failed to grow on culture 2/2 0/2
Strep.sanguinis 3 3/3 3/3 3/3 0/3
Strep.pneumoniae 5 4/5 0/5 No data No data
Strep.cristatus 2 2/2 0/2 1/2 0/2
Bacteroides vulgaris 2 1/2 0/2 No data No data
Klebsiella pneumoniae 3 3/3 3/3 3/3 0/3
Staphylococcus hominis 8 8/8Not identified as clinically
insignificant 4/8 0/4
Coryne.pseudodiptheriticum 2 2/2 1/2 0/2 0/2
Propionobacterium acnes 1 1/1 Failed to grow on culture 0/1 0/1
Klebsiella oxytoca 8 8/8 8/8 No data No data
Staphylococcus aureus 13 13/13 13/13 8/13 0/8
Enterococcus faecalis 2 2/2 2/2 2/2 2/2
Streptococcus salivarus 2 2/2 0/2 No data No data
Corynebacterium .acolens 2 2/2 0/2 0/2
Staphylococcus haemolyticus 2 2/2Not identified as clinically
insignificant 2/2 0/2
Micrococcus luteus 2 2/2 2/2 0/2 0/2
Nocardia farcinia 2 0/2 0/2 No data No data
Bacteroides sp 1 0/1 0/1 No data No data
Corynebacterium species 2 0/2 2/2 0/2 0/2
Misc Gram bacilli 4 0/4 0/4 No data No data
Total 133*
Results
Blood cultures new scoring system
79.49%
6.41%
14.10%
Direct Culture new scoring system
92.86%
7.14%
MALDI successfully identified 86.0% of organisms direct from blood
culture and 92.9% of organisms by extraction
Results
• Identified organisms present in the blood culture that
failed to grow
• Possible explanantions why some organisms did not
have identification
- Charcoal bottle
- Scanty organism present
- Organism not present in the database
- Mixed culture
Discussion
• MALDI-TOF successfully identified 85.9% of isolates direct from blood culture bottles in less than one hour.
• As demonstrated in this project the extraction of the organism direct from the blood culture can be taken to the storage of ethanol stage and then stored for processing at a different laboratory if necessary. This means that hospital sites without a MALDI-TOF can still use the technology.
• MALDI-TOF is very cost effective compared to our current identification system. Direct blood culture analysis costs £2-£4 per isolate and direct colony smear only 5p. Our current method costs £5 per isolate and cannot be done using positive blood direct from the bottle so result is only available on day 2.
• The new scoring system developed by Bruker allows greater confidence with the identification obtained by MALDI-TOF MS and as our results show it allowed us to confidently identify 11.54% more isolates.
Impact on Clinical Management
• 2 cases showed a potential to change antibiotic therapy due to results being available at an early stage.
• In one case Enterococcus faecalis was not identified until day 2 by our current method. Having a day 1 result would have resulted in a change of therapy.
• In a second case antibiotic therapy was given on the basis of GPC in the Gram film. The organism was identified to be S.epidermidis. Day 1 identification would have led to a de-escalation of antibiotic therapy as the organism was not significant in this case.
• Based on available clinical data the majority of cases to date in this study would not have yielded an escalation or de-escalation of antibiotic therapy however from a specialist point of view antibiotic management/stewardship will be aided by -– a) Day 1 identification of S.aureus to distinguish it from Coagulase Negative Staphylococci to
result in more focussed early therapy as well as avoidance of unnecessary antibiotics.
– b) Identification of Pseudomonas, Serratia, Enterobacter spp and Citrobacter as first line empirical Gram Negative Therapy is not generally directed at these organisms.
Future developments
• Future developments could be to directly
extract organisms from other fluids e.g.
CSF and synovial fluid to obtain a direct
organism identification and diagnosis of
infection and TB.
• Implementation into routine laboratory
• Potential to carry out typing with new
software
Thank you
• Thank you to Bruker for sponsoring the MSc project
• I would like to thank Craig, Erika and Michael for all the help and their continued support whilst carrying out the MSc
• Thanks to the staff at the Royal Liverpool Hospital for allowing us to work there
• Thank you to Kelly Ward and Jen Hancock for their help and support